32 results on '"Roussou, Euthalia"'
Search Results
2. Spondyloarthritis in African Populations Compared to Europeans Living in the United Kingdom
3. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells
4. Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive
5. The Semantics of ‘Hip Pain’ and its Impact on Clinical Practice in Patient-Reported Outcome Measures (PROMs) of Disease: Results from a Clinical and Radiological Evaluation Cohort
6. AB1230 DISEASE ACTIVITY OF RHEUMATIC DISEASES DURING PREGNANCY COMPARED TO REPORTED DISEASE ACTIVITYPRIOR TO PREGNANCY AS OBTAINED FROM AN ANTENATAL RHEUMATOLOGY OBSTETRIC COMBINED CLINIC AND MODE OF DELIVERY
7. AB1229 RHEUMATIC DISEASES REMISSION DURING PREGNANCY: MYTH OR REALITY? FACT OR HOPE?
8. Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials
9. CNS Vasculitis in Anti-Synthetase Syndrome
10. Spondyloarthropathies: are there any differences between Caucasians and southeast Asians living in north-east London in terms of disease onset and progression subject to cultural, social and treatment applications
11. Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy
12. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
13. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
14. 232. REAL-LIFE DATA ON COMPARISON BETWEEN SECOND TUMOUR NECROSIS FACTOR INHIBITOR VERSUS BIOLOGICS WITH DIFFERENT MODE OF ACTION AFTER SECONDARY FAILURE OF INITIAL TUMOUR NECROSIS FACTOR INHIBITOR IN RHEUMATOID ARTHRITIS
15. Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA
16. Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis
17. Comparison between the intermalleolar distance measured on the couch and on the floor in axial spondyloarthritis
18. Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review
19. 226. Intermalleolar Distance: Measuring on the Couch Versus Measuring on the Floor
20. 227. Differences in Uveitis Versus Non-Uveitis Individuals with HLA-B27-Postive Spondyloarthritis with Regard to First Presenting Symptoms
21. 174. Effectiveness of Patient-Centred Education in Improving Self-Efficacy and Health Status in People with Rheumatoid-Arthritis
22. 298. Assessment of the Existing Criteria for Inflammatory Back Pain Among Patients with Fibromyalgia
23. Cross-sectional study assessing family members of psoriatic arthritis patients affected by the same disease: differences between Caucasian, South Asian and Afro-Caribbean populations living in the same geographic region
24. Phenotypic and clinical differences between Caucasian and South Asian patients with psoriatic arthritis living in North East London
25. Medical students’ attitude towards rheumatology training at foundation years’ level in the UK and rationale behind the students’ choice: results from a national survey
26. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
27. Methotrexate for rheumatoid arthritis patients who are on hemodialysis
28. Development of a structured on-site nursing program for training nurse specialists in rheumatology
29. Early spondyloarthritis in multiracial society: differences between gender, race, and disease subgroups with regard to first symptom at presentation, main problem that the disease is causing to patients, and employment status
30. The treatment of rheumatoid arthritis during pregnancy
31. Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides
32. The Bath Ankylosing Spondylitis Activity and Function Indices (BASDAI and BASFI) and their correlation with main symptoms experienced by patients with spondyloarthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.